within Pharmacolibrary.Drugs.ATC.N;

model N01AA02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0002,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N01AA02</td></tr><td>route:</td><td>inhalational</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Vinyl ether (ATC code N01AA02) is a volatile, inhalational general anesthetic drug that was previously used for induction and maintenance of anesthesia. Its use has been discontinued due to toxicity issues, including instability, flammability, and the risk of hepatic and renal injury. Vinyl ether is not an approved or commonly used anesthetic today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies or sources report explicit human PK parameters for vinyl ether. The following PK values are estimated based on standard practice for volatile anesthetics and historical account.</p><h4>References</h4><ol><li><p>Reichle, FM, et al., &amp; Peter, K (2002). Nephrotoxicity of halogenated inhalational anaesthetics: fictions and facts. <i>European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes</i> 34(1-2) 188–195. DOI:<a href=\"https://doi.org/10.1159/000048908\">10.1159/000048908</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11867922/\">https://pubmed.ncbi.nlm.nih.gov/11867922</a></p></li><li><p>Mazze, RI (2001). Composition of CO(2) absorbents. <i>Anesthesia and analgesia</i> 92(5) 1356–1357. DOI:<a href=\"https://doi.org/10.1097/00000539-200105000-00057\">10.1097/00000539-200105000-00057</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11323380/\">https://pubmed.ncbi.nlm.nih.gov/11323380</a></p></li><li><p>Vakilzadeh, H, et al., &amp; Minaiyan, M (2018). Pulmonary Delivery of Triptorelin Loaded in Pluronic Based Nanomicelles in Rat Model. <i>Current drug delivery</i> 15(5) 630–640. DOI:<a href=\"https://doi.org/10.2174/1567201815666180209113735\">10.2174/1567201815666180209113735</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29424314/\">https://pubmed.ncbi.nlm.nih.gov/29424314</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N01AA02;
